Antifungal persistence: Clinical relevance and mechanisms
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index; 92 of the 155 sources its claims cite were checked for support.
Abstract
Review defining antifungal persistence as survival of a subpopulation at high drug concentrations, distinct from tolerance and resistance, and emphasizing its phenotypic, reversible nature.
Overview
CoChat Summary
TL;DR
This review defines antifungal persistence as a non-heritable, population-level phenomenon in which a small subpopulation of dormant fungal cells survives high-dose antifungals without increased MIC, distinct from resistance, tolerance, and heteroresistance. It synthesizes detection methods, mechanisms, and clinical/treatment evidence, concluding that direct clinical outcome evidence and mechanistic understanding remain limited.
Key findings
- Antifungal persistence is heterogeneous: generally <<1% of the population survives, time-kill assays show similar MDK99 to susceptible strains but substantially higher MDK99.99, and MIC does not increase; unlike resistance, it is non-heritable.
- Mechanisms include a dormant low-metabolism state (downregulated glycolysis, TCA cycle, and PPP; reduced ATP; upregulated glyoxylate cycle and gluconeogenesis), stress responses (SODs, Ahp1, ergothioneine, Hsp12, Hsp90 family), and adhesion/biofilm initiation; AmB-tolerant persisters are absent in some Candida spp. biofilms, and dormancy alone is insufficient.
- Clinical relevance: in vivo models show higher fungal burden in persistent A. fumigatus isolates after voriconazole in Galleria mellonella and higher fungal burden plus echinocandin-resistance mutation rate in N. glabratus mouse infection; long-term C. albicans oral carriers had higher persistence, and persistent candidemia isolates showed high azole tolerance.
- Treatment: persisters are recalcitrant to multiple antifungals, but cited agents including sertraline, Lavandula angustifolia essential oil, polymethacrylates, VT-1161, and gH625-M can eradicate persisters in specific models; a SOD inhibitor reduced the persister fraction by 18-fold.
Methods
- Narrative review; no primary experiments. It synthesizes definitions, distinctions from resistance/tolerance/heteroresistance, detection methods, molecular mechanisms, and in vivo/clinical observations.
- Evidence base includes cited studies in Candida spp., Cryptococcus, Aspergillus, and other fungi, using in vitro assays, animal models, and clinical observations.
- Main analysis is qualitative synthesis with figures and a treatment table; no systematic review search strategy is stated.
Limitations
- The paper states that conclusive evidence directly tying fungal persistence to clinical outcomes such as recurrent infections is still lacking, and that mechanisms remain poorly defined and multifactorial.
- The paper notes that AmB-tolerant persisters are absent in biofilms of some Candida spp., dormancy alone is insufficient, energy-metabolism studies are predominantly in biofilms and may not apply to planktonic cells, and adhesion research is limited to biofilm-associated genes, lacks specific pathways, and covers limited species.
- Evident from the text: as a narrative review, it reports no primary data or systematic search; some mechanisms are presented as likely rather than proven in persisters, as indicated by the figure legends distinguishing solid and dashed lines.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
66 Valid · 4 Not valid · 38 Not checked · 22 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A study in the Galleria mellonella mini-host model of A. fumigatus infection found that fungal burden of the larvae infected with persistent isolates was significantly higher than non-persistent isolates after voriconazole treatment [4].”
§ Antifungal persistence: Clinical relevance and mechanisms > Clinical relevance of antifungal persistence > 1. Potential outcome of antifungal persistence
What the sources say
- Disputedcites [4] J Scott, 2023, Aspergillus fumigatus can display persistence to the fungicidal drug voriconazole, Microbiol Spectr sourceExperimental — accuracy not yet measured
The Results (Fig. 7) report higher mean fungal burden in voriconazole-treated larvae infected with persister isolates, but explicitly say the differences from nonpersister isolates were not significant. The claim's assertion of statistical significance contradicts that finding. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“N. glabratus persisters are recalcitrant to echinocandins and AmB [38].”
§ Antifungal persistence: Clinical relevance and mechanisms > Clinical relevance of antifungal persistence > 2. Treatment targeting antifungal persistence
What the sources say
- Disputedcites [38] A Arastehfar, 2023, Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance, Nat Commun sourceExperimental — accuracy not yet measured
The Results section reports that intracellular C. glabrata persisters are highly tolerant to echinocandins, supporting that part of the claim. But the section titled “Micafungin-tolerant ICG are effectively killed by amphotericin B” reports the opposite for AmB: following micafungin with amphotericin B significantly reduced persister numbers. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Dormant cells have been observed in various cases of antifungal persistence, such as in AmB-tolerant C. albicans biofilms and in a mouse model of pulmonary cryptococcosis [3,33].”
§ Antifungal persistence: Clinical relevance and mechanisms > Mechanisms of antifungal persistence formation > 1. Dormant state promotes antifungal persistence
What the sources say
- Supportedcites [3] W Ke, 2024, Fungicide-tolerant persister formation during cryptococcal pulmonary infection, Cell Host Microbe source
The Results describe dormant C. neoformans cells in a murine inhalation model and investigate their relationship to AmB persisters. The Discussion reports that AmB persisters in the mouse lung are enriched in cells producing stationary-phase indicators. This supports the pulmonary-cryptococcosis example attributed to this source; the separate C. albicans biofilm example is not assessed here. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [33] P Li, 2015, Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters, Antimicrob Agents Chemother source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study has found that reduced ATP synthesis due to limited respiration may be a key mechanism of AmB-tolerant Cryptococcus neoformans persisters formation [3].”
§ Antifungal persistence: Clinical relevance and mechanisms > Mechanisms of antifungal persistence formation > 1. Dormant state promotes antifungal persistence
What the sources say
- Supportedcites [3] W Ke, 2024, Fungicide-tolerant persister formation during cryptococcal pulmonary infection, Cell Host Microbe source
The Results section states that arsenate-induced inhibition of ATP synthesis increased survival under AmB treatment and concludes that reduced ATP synthesis due to limited respiration may be a key mechanism of AmB persistence in C. neoformans stationary-phase cells. This matches the citing sentence’s hedged claim. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, antifungal tolerance and persistence are often overlooked [17,47].”
§ Antifungal persistence: Clinical relevance and mechanisms > Clinical relevance of antifungal persistence > 1. Potential outcome of antifungal persistence
What the sources say
- Partly supportedcites [17] E Delarze, 2015, Defining the frontiers between antifungal resistance, tolerance and the concept of persistence, Drug Resist Updat sourceExperimental — accuracy not yet measured
The Abstract and §4 describe antifungal tolerance as an ignored or neglected area. Section 5 says persistence after therapy is neglected in most animal-model reports, while noting that relapses matter clinically. These passages support the broad point that both receive insufficient attention, but do not establish that they are often overlooked in clinical practice. (LLM, conf=0.85)
- Partly supportedcites [47] A Rosenberg, 2018, Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia, Nat Commun sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says antifungal tolerance is rarely quantified and that current clinical recommendations suggest ignoring it. The paper also says standard MIC testing may miss the risk of persistent infection, but it does not say that persistence itself is often overlooked in clinical practice. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
75 more claims · 38 with their cited sources checked
Create a free account to see all 130 claims and to verify the 6 references still open.
- It may state two separate claims as one. 42
- Probably not a substantial claim. 15
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Antifungal persistence: Clinical relevance and mechanisms > Clinical relevance of antifungal persistence > 2. Treatment targeting antifungal persistence
“Lavandula angustifolia essential oil, which can provoke intracellular reactive oxygen species (ROS) accumulation, has been found to successfully eradicate caspofungin-triggered Candida auris biofilm persisters [14].”
§ Antifungal persistence: Clinical relevance and mechanisms > Clinical relevance of antifungal persistence > 2. Treatment targeting antifungal persistence
“| Lavandula angustifoliaessential oil | CRYPT auris | Biofilm in vitro | Caspofungin-tolerant | [14] |”
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 1×
“Over time, the persistent subpopulation emerges and maintains viability, leading to longer minimum treatment durations required for 99.99% population eradication (MDK 99.99 ) [15,17,20,21] (Fig 1).”
InfluentialDonnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 1×
“It has been well studied that dormant state reduces the exposure of antibiotic targets and helps bacterial cells tolerate a variety of antibiotics, a process linked to the toxin-antitoxin system [18,54].”
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858 · cited 2×
“Fungal persisters are dormant variants of wild-type cells that are tolerant to antifungal drugs, surviving high dosage of antifungals that exceed the minimal inhibitory concentration (MIC) [12,16].”
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612 · cited 2×
“For a long time, characteristic biphasic-killing curve observed in the time-kill assay and survival rate evaluated by colony-forming unit (CFU) counting were the only ways to identify and evaluate antifungal persistence in vitro [15,20].”
InfluentialRespiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport
Fernie, A. R., Carrari, F., & Sweetlove, L. J. (2004) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2004.03.007 · Cited by 1,403 · cited 1×
“TCA cycle provides nicotinamide adenine dinucleotide as a substrate for the oxidative respiratory chain, generating a large amount of ATP [57].”
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313 · cited 4×
“For a long time, characteristic biphasic-killing curve observed in the time-kill assay and survival rate evaluated by colony-forming unit (CFU) counting were the only ways to identify and evaluate antifungal persistence in vitro [15,20].”
InfluentialTREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025 · cited 1×
“In bacteria, the addition of glycolysis intermediates can kill aminoglycoside-induced persisters [56], but such phenomenon has not been observed in fungi.”
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866 · cited 1×
“Amphotericin B which belongs to polyenes class, due to its potent fungicidal activity and the rarity of resistance [35–37], has been widely studied and shown to induce antifungal persistence in Candida spp. biofilms and Trichosporon spp. Reports on echinocandin-associated persistence are primarily…”
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850 · cited 1×
“In contrast, resistance is linked to specific molecular mechanisms and can be stably inherited by progeny [15,17–19].”
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738 · cited 1×
“Biofilm formation helps fungal cells survive antifungal treatment by secreting extracellular matrix and enhancing drug efflux pump activity, which is closely related to antifungal tolerance and resistance [75–77].”
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642 · cited 1×
“In vitro assay that can quantify both susceptibility (measured as MIC at 24 h) and growth properties at 48 h (the fraction of growth or supra-MIC growth) was recommended to use [23].”
Amphotericin primarily kills yeast by simply binding ergosterol
Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117280109 · Cited by 608
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
ATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508 · cited 1×
“It has been well studied that dormant state reduces the exposure of antibiotic targets and helps bacterial cells tolerate a variety of antibiotics, a process linked to the toxin-antitoxin system [18,54].”
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502
The translationally controlled tumour protein (TCTP)
Bommer, U.-A., & Thiele, B.-J. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00213-9 · Cited by 447
Chandel, N. S. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040535 · Cited by 437 · cited 1×
“Glycolysis is an important and highly conserved energy-generating pathway, independent of oxygen [55].”
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Wootton, M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.399 · Cited by 414 · cited 1×
“The population analysis profile assay is used as gold standard for detecting heteroresistance [31].”
Intracellular Staphylococcus aureus persisters upon antibiotic exposure
Peyrusson, F., Varet, H., Nguyen, T. K., Legendre, R., Sismeiro, O., Coppée, J.-Y., Wolz, C., Tenson, T., & Van Bambeke, F. (2020) · Nature Communications · doi:10.1038/s41467-020-15966-7 · Cited by 392
Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB
Schumacher, M. A., Piro, K. M., Xu, W., Hansen, S., Lewis, K., & Brennan, R. G. (2009) · Science · doi:10.1126/science.1163806 · Cited by 351 · cited 1×
“Another study of antibiotic persistence indicated that HipA, a transcription inhibitor, mediates the formation of Escherichia coli persisters through phosphorylation of EF-Tu [61], but it has not been reported in fungi.”
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 1×
“Hsp90 is central to stress response pathways in fungi, mediating antifungal tolerance and resistance through its interactions with key client proteins: protein phosphatase calcineurin and components of the PKC cell wall integrity pathway [66,74].”
Stress-activated Genomic Expression Changes Serve a Preparative Role for Impending Stress in Yeast
Berry, D. B., & Gasch, A. P. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0680 · Cited by 326 · cited 1×
“Hsp12 is part of the environmental stress response and plays a crucial role in protecting cells from severe stress, likely contributing to the formation and maintenance of persistence [73].”
Gravelat, F. N., Beauvais, A., Liu, H., Lee, M. J., Snarr, B. D., Chen, D., Xu, W., Kravtsov, I., Hoareau, C. M. Q., Vanier, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003575 · Cited by 320 · cited 1×
“It has been proven that GAG can directly enhance adhesion of A. fumigatus to host cells or material surfaces [80].”
Combination Treatment of Invasive Fungal Infections
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., & Ghannoum, M. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.163-194.2005 · Cited by 308
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Candida albicans biofilm–induced vesicles confer drug resistance through matrix biogenesis
Zarnowski, R., Sanchez, H., Covelli, A. S., Dominguez, E., Jaromin, A., Bernhardt, J., Mitchell, K. F., Heiss, C., Azadi, P., Mitchell, A., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006872 · Cited by 260
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237 · cited 2×
“LaFleur and colleagues reported that isolates from cancer patients with long-term C. albicans oral colonization displayed significantly higher levels of persistence compared to those from short-term carriers [13].”
Combinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2017) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 218 · cited 1×
“When antifungal therapy fails, the development of drug resistance is a common explanation and clinicians may change the regimen to another drug or use combination therapy [7,8].”
A central role for the peroxisomal membrane in glyoxylate cycle function
Kunze, M., Pracharoenwattana, I., Smith, S. M., & Hartig, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.009 · Cited by 211 · cited 1×
“Glyoxylate cycle is an alternative pathway of TCA cycle, providing precursors for amino acid biosynthesis or carbohydrate biosynthesis [58].”
Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179
von Lilienfeld-Toal, M., Wagener, J., Einsele, H., Cornely, O. A., & Kurzai, O. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0271 · Cited by 164
Chauhan, N., Inglis, D., Roman, E., Pla, J., Li, D., Calera, J. A., & Calderone, R. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.5.1018-1024.2003 · Cited by 159 · cited 1×
“Ahp1 is a member of the peroxiredoxin family, cooperates with other peroxidase such as Trx1 to protect cells from ROS [69].”
Da Silva Ferreira, M. E., Colombo, A. L., Paulsen, I., Ren, Q., Wortman, J., Huang, J., Goldman, M. H. S., & Goldman, G. H. (2005) · Medical Mycology · doi:10.1080/13693780400029114 · Cited by 158
Ras pathway signaling accelerates programmed cell death in the pathogenic fungus Candida albicans
Phillips, A. J., Crowe, J. D., & Ramsdale, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506405103 · Cited by 147 · cited 1×
“In C. albicans , upregulation of Ras-cAMP-PKA signaling pathway accelerates cell apoptosis [71], but there is no direct evidence that this pathway is involved in the formation of persisters.”
Fungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136 · cited 4×
“Fungal persisters are dormant variants of wild-type cells that are tolerant to antifungal drugs, surviving high dosage of antifungals that exceed the minimal inhibitory concentration (MIC) [12,16].”
InfluentialSuperoxide dismutases are involved in Candida albicans biofilm persistence against miconazole
Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P. A., & Thevissen, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-11 · Cited by 119 · cited 1×
“Moreover, the persister fraction reduced by 18-fold once cells treated with a SOD inhibitor N,N-diethyldithiocarbamate [68].”
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118 · cited 5×
“Given that azoles are fungistatic to most yeast pathogens, it can be challenging to determine whether azole tolerance is associated with persistence or the inherent properties of the drug itself [17].”
InfluentialHeteroresistance of Cryptococcus gattii to Fluconazole
Varma, A., & Kwon-Chung, K. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-10 · Cited by 103
Rinnerthaler, M., Jarolim, S., Heeren, G., Palle, E., Perju, S., Klinger, H., Bogengruber, E., Madeo, F., Braun, R. J., Breitenbach-Koller, L., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.05.022 · Cited by 101 · cited 1×
“Previous studies have shown compromise of cell cycle progression and prolongation of cell life in absence of TMA19 [59,60].”
The eagle effect and antibiotic-induced persistence: two sides of the same coin?
Prasetyoputri, A., Jarrad, A. M., Cooper, M. A., & Blaskovich, M. A. T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.10.007 · Cited by 101 · cited 1×
“Notably, the paradoxical effect, also known as the “Eagle effect”, often observed in echinocandins may confused with antifungal persistence, as the drugs show reduced activity in vitro at higher concentrations [40,41].”
Absence of Amphotericin B-Tolerant Persister Cells in Biofilms of Some Candida Species
Al-Dhaheri, R. S., & Douglas, L. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-07 · Cited by 99 · cited 1×
“Notably, AmB-tolerant persister cells are absent in biofilms of some Candida spp. , suggesting that antifungal persistence is not a common phenomenon [79,82].”
Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95 · cited 7×
“Specifically, phosphoglycerate kinase (Pgk1) and hexokinase-2 (Hxk2) involved in glycolysis, together with isocitrate dehydrogenase (Idh2) and malate dehydrogenase (Mdh1) involved in TCA cycle are down-regulated [33].”
InfluentialHayes, B. M. E., Anderson, M. A., Traven, A., van der Weerden, N. L., & Bleackley, M. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1573-8 · Cited by 93
Ben-Ami, R., Zimmerman, O., Finn, T., Amit, S., Novikov, A., Wertheimer, N., Lurie-Weinberger, M., & Berman, J. (2016) · mBio · doi:10.1128/mbio.00655-16 · Cited by 88 · cited 1×
“Antifungal heteroresistance was first been found in C. neoformans and Cryptococcus gattii , and was considered as an intrinsic property of these species, associating with disomic chromosomes [24–27].”
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
Apoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81 · cited 2×
“ROS caused by AmB may lead to histone acetylation and activate apoptosis in persisters, highlighting the important role of HDA in protection against apoptosis and persistence formation [32].”
Jacobsen, I. D., Lüttich, A., Kurzai, O., Hube, B., & Brock, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku198 · Cited by 73 · cited 2×
“Another investigation utilizing a murine model of systemic C. albicans infection demonstrated that although antifungal treatment achieved substantial eradication of fungal cells, persistent pathogen reservoirs were consistently detected in gallbladder tissue during long-term monitoring [48].”
Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625
Galdiero, E., de Alteriis, E., De Natale, A., D’Alterio, A., Siciliano, A., Guida, M., Lombardi, L., Falanga, A., & Galdiero, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62746-w · Cited by 65
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
Self-citationZhai, B., Liao, C., Jaggavarapu, S., Tang, Y., Rolling, T., Ning, Y., Sun, T., Bergin, S. A., Gjonbalaj, M., Miranda, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03183-4 · Cited by 62 · cited 1×
“Moreover, a recent study found that antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections in patients during allogeneic hematopoietic cell transplantation [30].”
Shetty, S., Hofstetter, J., Battaglioni, S., Ritz, D., & Hall, M. N. (2023) · The EMBO Journal · doi:10.15252/embj.2022112344 · Cited by 58 · cited 1×
“A recent study has found that TORC1 can regulate ribosomal dormancy in an evolutionarily conserved manner by directly targeting a ribosome preservation factor [63].”
Arastehfar, A., Daneshnia, F., Cabrera, N., Penalva-Lopez, S., Sarathy, J., Zimmerman, M., Shor, E., & Perlin, D. S. (2023) · Nature Communications · doi:10.1038/s41467-023-36882-6 · Cited by 58
Ngamskulrungroj, P., Chang, Y., Hansen, B., Bugge, C., Fischer, E., & Kwon-Chung, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033022 · Cited by 56
de Alteriis, E., Maione, A., Falanga, A., Bellavita, R., Galdiero, S., Albarano, L., Salvatore, M. M., Galdiero, E., & Guida, M. (2021) · Antibiotics · doi:10.3390/antibiotics11010026 · Cited by 54
Brain glucose induces tolerance of Cryptococcus neoformans to amphotericin B during meningitis
Chen, L., Tian, X., Zhang, L., Wang, W., Hu, P., Ma, Z., Li, Y., Li, S., Shen, Z., Fan, X., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01561-1 · Cited by 46 · cited 1×
“For fungicidal agents, MDK 99 and MDK 99.99 can also be used to detect fungicidal tolerance, such as detecting the tolerance of Cryptococcus neoformans to AmB [22].”
InfluentialSelf-citationTruong, T., Zeng, G., Qingsong, L., Kwang, L. T., Tong, C., Chan, F. Y., Wang, Y., & Seneviratne, C. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061523 · Cited by 45 · cited 1×
“Studies indicate that Ahp1 can be directly or indirectly regulated by Ira2, an inhibitory regulator of the RAS-cAMP pathway [70].”
Coupling phenotypic persistence to DNA damage increases genetic diversity in severe stress
Yaakov, G., Lerner, D., Bentele, K., Steinberger, J., & Barkai, N. (2017) · Nature Ecology & Evolution · doi:10.1038/s41559-016-0016 · Cited by 45 · cited 2×
“Under stress conditions, cells with high expression of heat-shock protein 12 (Hsp12) survived better than those with normal expression, suggesting that Hsp12 is a possible molecular marker of persistence [45].”
Fungicide-tolerant persister formation during cryptococcal pulmonary infection
Ke, W., Xie, Y., Chen, Y., Ding, H., Ye, L., Qiu, H., Li, H., Zhang, L., Chen, L., Tian, X., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.012 · Cited by 45 · cited 8×
“Ergothioneine works synergically with glutathione to enhance tolerance to ROS, thereby supporting persistence in stationary-phase cells [3].”
InfluentialSelf-citationBojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42 · cited 1×
“Further, this study extended this mechanism to the clinical pathogenic fungi C. albicans and N. glabratus [62].”
Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens
Yang, F., & Berman, J. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102439 · Cited by 42 · cited 1×
“In multiple murine infection models, Heteroresistant strains can lead to increased fungal burden and reduced treatment efficacy [28,29].”
Trichosporon asahii and Trichosporon inkin biofilms produce antifungal-tolerant persister cells
Cordeiro, R. D. A., Aguiar, A. L. R., da Silva, B. N., Pereira, L. M. G., Portela, F. V. M., de Camargo, Z. P., de Lima-Neto, R. G., Castelo-Branco, D. D. S. C. M., Rocha, M. F. G., & Sidrim, J. J. C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.645812 · Cited by 34
Candida albicans amphotericin B-tolerant persister formation is closely related to surface adhesion
Sun, J., Li, Z., Chu, H., Guo, J., Jiang, G., & Qi, Q. (2016) · Mycopathologia · doi:10.1007/s11046-015-9894-1 · Cited by 32 · cited 3×
“Antifungal persistence is most commonly observed in biofilm rather than in planktonic cells [2,33,34], highlighting the critical role of biofilm formation in antifungal persistence.”
InfluentialCandida albicans Biofilms Are Generally Devoid of Persister Cells
Denega, I., d’Enfert, C., & Bachellier-Bassi, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01979-18 · Cited by 32
The eagle-like effect of echinocandins: what’s in a name?
Vanstraelen, K., Lagrou, K., Maertens, J., Wauters, J., Willems, L., & Spriet, I. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.841543 · Cited by 28 · cited 1×
“Notably, the paradoxical effect, also known as the “Eagle effect”, often observed in echinocandins may confused with antifungal persistence, as the drugs show reduced activity in vitro at higher concentrations [40,41].”
Oxidative imbalance in Candida tropicalis biofilms and its relation with persister cells
da Silva, M. A., Baronetti, J. L., Páez, P. L., & Paraje, M. G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.598834 · Cited by 28
Aspergillus fumigatus Can Display Persistence to the Fungicidal Drug Voriconazole
Scott, J., Valero, C., Mato-López, Á., Donaldson, I. J., Roldán, A., Chown, H., Van Rhijn, N., Lobo-Vega, R., Gago, S., Furukawa, T., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04770-22 · Cited by 24
Wu, X., Zhang, S., Xu, X., Shen, L., Xu, B., Qu, W., Zhuang, W., Locock, K., Deighton, M., & Qu, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02592 · Cited by 23 · cited 1×
“In a mouse model of vulvovaginal candidiasis, polymethacrylates was more effective at eradicating persisters and induced lower levels of persistence on their own, compared to conventional antifungals such as clotrimazole and nystatin [51].”
Are all antibiotic persisters created equal?
Shultis, M. W., Mulholland, C. V., & Berney, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933458 · Cited by 19 · cited 1×
“In antibiotic persistence, persisters are often recalcitrant to multiple antibiotics [49,50], which has been observed with fungal persisters as well.”
Arastehfar, A., Daneshnia, F., Floyd, D. J., Jeffries, N. E., Salehi, M., Perlin, D. S., Ilkit, M., Lass-Flöerl, C., & Mansour, M. K. (2024) · mBio · doi:10.1128/mbio.00072-24 · Cited by 19 · cited 5×
“For example, echinocandin-tolerant persisters were found in the mouse model of N. glabratus systematic infection [39]; and AmB-tolerant persisters were found in Cryptococcus pulmonary infection mouse model [3].”
InfluentialInsight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
Amich, J., Bromley, M., Goldman, G. H., & Valero, C. (2025) · mBio · doi:10.1128/mbio.03475-24 · Cited by 14
How do I manage refractory invasive pulmonary aspergillosis
Vergidis, P., Sendi, P., Alkhateeb, H. B., & Nguyen, M. H. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.01.015 · Cited by 12 · cited 1×
“However, in some cases, even though devoid of resistance, the clinical treatment still failed, leading to breakthrough or recurrent infections [9–11].”
Aboualigalehdari, E., Tahmasebi Birgani, M., Fatahinia, M., & Hosseinzadeh, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651221 · Cited by 11
Flow cytometry-based method to detect persisters in Candida albicans
Chang, W., Zhang, M., Li, Y., & Lou, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00255-15 · Cited by 7
Sinoca, M., Maione, A., Gambino, E., Imparato, M., Galdiero, M., de Alteriis, E., Galdiero, E., & Guida, M. (2024) · Biomedicines · doi:10.3390/biomedicines12020389 · Cited by 7
Sun, J., Liu, X., Jiang, G., & Qi, Q. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03765-14 · Cited by 6 · cited 2×
“For example, using a scanning confocal microscope, fluorescein diacetate can stain live cells green, whereas propidium iodide (PI) stains dead cells red, enabling the visual identification of persisters [2,12,43].”
Research works printed but not linked: 2
- A Brauner, 2016, Distinguishing between resistance, tolerance and persistence to antibiotic treatment, Nat Rev Microbiol, 14, 320, 10.1038/nrmicro.2016.34 · DOI · Paper page
- K Lewis, 2010, Persister cells, Annu Rev Microbiol, 64, 357, 10.1146/annurev.micro.112408.134306 · DOI · Paper page
Cited by
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
Debta, P., Sahu, B. K., Patra, S. K., Debta, F. M., Mishra, E., & Panda, S. K. (2026) · Frontiers in Antibiotics · doi:10.3389/frabi.2026.1767028 · Cited by 8
“…single-cell transcriptomics, metabolic reporters, or molecular signatures) that could be utilized as candidate biomarkers for persistence-enriched states; however, these technologies still require controlled clinical studies for further validation and optimization (Chen, 2025; Wang et al., 2025).”
Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden
Baral, B. (2026) · ChemFoodChem · doi:10.1002/cfch.70026 · Cited by 2
Bacterial heteroresistance mechanisms, dynamics, and emerging diagnostic approaches
Brameyer, S. (2026) · Bioscience Reports · doi:10.1042/bsr20260035 · Cited by 1
“The conceptual parallel between bacterial heteroresistance and fungal persistence underscores that population heterogeneity under antimicrobial stress is a cross-kingdom phenomenon with shared evolutionary logic but lineage-specific molecular underpinnings [64].”
Mantilla, M. J., Tebbji, F., Vincent, A. T., Villeneuve, L. R., Chatr‐aryamontri, A., & Sellam, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.21.719916
Prevalence and phenotypic features of voriconazole persistence in Aspergillus fumigatus
Li, X., Zhou, Z., Lin, H., Guo, J., Wu, W., Goldman, G. H., Lu, L., & Zhang, Y. (2026) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2026.2679240
Metadata
- Authors
- Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H.
- Affiliations
- Second Affiliated Hospital of Soochow University (CN)
- University at Buffalo, State University of New York (US)
- Corresponding author
- Du, Hong
- Venue
- PLoS pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2025-09-11
- Volume
- 21
- Issue
- 9
- Pages
- e1013456
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC12425288
- OpenAlex
- W4414154061
- Semantic Scholar
- 352843f4aea9004e61524a11e87fa74fce25ea10
- Cited by
- 12
- References
- 80
- Citations by year
- 2026: 12
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Key Research and Development Project of Jiangsu Provincial Science and Technology Department (BE2023704)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- antifungal resistance, antifungal tolerance, chronic fungal infection, recurrent fungal infection
- MeSH terms
- Clinical Relevance, Animals, Antifungal Agents, Fungi, Humans, Mycoses, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.